Synexus is a clinical research site located in Dallas, Texas, United States 75234.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Synexus has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Nonalcoholic Steatohepatitis, Obesity, Osteoarthritis, Knee.
Sponsors: Tobira Therapeutics, Inc., NuSirt Biopharma, Eli Lilly and Company.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Synexus has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Synexus has 3 clinical trials on record, with 1 currently active. Their work covers Nonalcoholic Steatohepatitis, Obesity, Osteoarthritis, Knee.
Synexus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.